AI assistant
Sending…
Bodal Chemicals Ltd — Capital/Financing Update 2021
Feb 9, 2021
61062_rns_2021-02-09_23ffab43-95eb-4d60-9d6e-f6376a126e51.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer

| Statement of Deviation/ Variation in utilisation of Funds raised through Preferential Allotment | ||||||
|---|---|---|---|---|---|---|
| Name of listed Entity | BODAL CHEMICALS LIMITED | |||||
| Mode of Fund Raising | Fund raised through issue and allott Equity Warrants-through preferential allotment' | |||||
| Date of Raising Funds | 11-07-2019 | |||||
| Amount Raised | 431250000/- (Forty Three Crore Twelve La kh Fifty Thousands) | |||||
| Report flied for Quarter ended | For Quart er ended on 31st December 2021 | |||||
| Monitoring Agency | Not Applicable | |||||
| Monitoring Agency Name, if applicable | Not Applicable | |||||
| Is there a Deviation/Variation in the use of funds raised |
No | |||||
| If yes, Whether the same is pursuant to | ||||||
| Change in terms of Contract or Object, which was aproved by the Shareholders |
--- | |||||
| If yes, Date of Share holder approval | --- | |||||
| Explanation for the Deviation/ Variation | --- | |||||
| Comments of the Audit Committee After | ||||||
| review | --- | |||||
| --- | ||||||
| Comments of the Auditors, if any Object for which funds have been raised and where there has been a deviation, In the following table :-Not Applicable |
||||||
| Original Objects | Modified Object, if any | Original Allocation |
Modified Allocation, if any |
Funds Utilised |
Amount of Deviation/Variation for the quarter according to applicable object |
Remarks if any |
| Deviation or variation could mean: | Not Applicable |
HEAD OFFICE:
I Plot No. 123-124, Phase-1, G.l.D.C, Vatva, Ahmedabad- 382 445., Gujarat, India.
www.bodal.com CIN No. : L24 ll 0GJl 986PLC009003 Tel: +91 79 2583 5437 2583 4223, 25831684 Fax: +91 2583 5245, 25836052 E-mail: [email protected]

More from Bodal Chemicals Ltd
Regulatory Filings
2026
Jun 5
Regulatory Filings
2026
Jun 5
Regulatory Filings
2026
May 26
Report Publication Announcement
2026
May 22
Report Publication Announcement
2026
May 22
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 21
Investor Presentation
2026
May 21
Investor Presentation
2026
May 21
Audit Report / Information
2026
May 21